• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本临床肿瘤学组研究JCOG0304中Ki-67系统在软组织肉瘤组织学分级中的前瞻性评估。

Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304.

作者信息

Tanaka Kazuhiro, Hasegawa Tadashi, Nojima Takayuki, Oda Yoshinao, Mizusawa Junki, Fukuda Haruhiko, Iwamoto Yukihide

机构信息

Department of Endoprosthetic Surgery, Oita University, Yufu, Oita, 879-5593, Japan.

Department of Surgical Pathology, Sapporo Medical University School of Medicine, South 1 West 16, Chuo-ku, Sapporo, 060-8543, Japan.

出版信息

World J Surg Oncol. 2016 Apr 18;14:110. doi: 10.1186/s12957-016-0869-6.

DOI:10.1186/s12957-016-0869-6
PMID:27091124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4836080/
Abstract

BACKGROUND

The correct clinical staging of soft tissue sarcomas (STS) is critical for the selection of treatments. The staging system consists of histological grade of the tumors and French Federation of Cancer Center (FNCLCC) system based on mitotic count is widely used for the grading. In this study, we compared the validity and usefulness of Ki-67 grading system with FNCLCC system in JCOG0304 trial which investigated the efficacy and safety of perioperative chemotherapy with doxorubicin and ifosfamide for STS.

METHODS

All 70 eligible patients with STS in the extremities treated by perioperative chemotherapy in JCOG0304 were analyzed. Univariate and multivariate Cox regression analyses were conducted to investigate an influence on overall survival.

RESULTS

The reproducibility of Ki-67 grading system in the histological grading of STS was higher than FNCLCC system (κ = 0.54 [95 % CI 0.39-0.71], and 0.46 [0.32-0.62], respectively). Although FNCLCC grade was not associated with overall survival (OS) in univariate analysis (HR 2.80 [0.74-10.55], p = 0.13), Ki-67 grading system had a tendency to associate with OS in univariate analysis (HR 4.12 [0.89-19.09], p = 0.07) and multivariate analysis with backward elimination (HR 3.51 [0.75-16.36], p = 0.11).

CONCLUSIONS

This is the first report demonstrating the efficacy of Ki-67 grading system for the patients with STS in the prospective trial. The results indicate that Ki-67 grading system might be useful for the evaluation of histological grade of STS.

摘要

背景

软组织肉瘤(STS)的正确临床分期对于治疗方案的选择至关重要。分期系统包括肿瘤的组织学分级,基于有丝分裂计数的法国癌症中心联合会(FNCLCC)系统被广泛用于分级。在本研究中,我们在JCOG0304试验中比较了Ki-67分级系统与FNCLCC系统在评估多柔比星和异环磷酰胺围手术期化疗治疗STS的疗效和安全性方面的有效性和实用性。

方法

对JCOG0304中所有70例接受围手术期化疗的符合条件的四肢STS患者进行分析。进行单因素和多因素Cox回归分析以研究对总生存期的影响。

结果

Ki-67分级系统在STS组织学分级中的可重复性高于FNCLCC系统(κ分别为0.54 [95%CI 0.39 - 0.71]和0.46 [0.32 - 0.62])。虽然在单因素分析中FNCLCC分级与总生存期(OS)无关(HR 2.80 [0.74 - 10.55],p = 0.13),但Ki-67分级系统在单因素分析中有与OS相关的趋势(HR 4.12 [0.89 - 19.09],p = 0.07),在多因素向后逐步回归分析中也是如此(HR 3.51 [0.75 - 16.36],p = 0.11)。

结论

这是第一份在前瞻性试验中证明Ki-67分级系统对STS患者有效的报告。结果表明Ki-67分级系统可能有助于评估STS的组织学分级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e111/4836080/ccff3b2933e4/12957_2016_869_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e111/4836080/c9499b373852/12957_2016_869_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e111/4836080/b65dff681b75/12957_2016_869_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e111/4836080/ccff3b2933e4/12957_2016_869_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e111/4836080/c9499b373852/12957_2016_869_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e111/4836080/b65dff681b75/12957_2016_869_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e111/4836080/ccff3b2933e4/12957_2016_869_Fig3_HTML.jpg

相似文献

1
Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304.日本临床肿瘤学组研究JCOG0304中Ki-67系统在软组织肉瘤组织学分级中的前瞻性评估。
World J Surg Oncol. 2016 Apr 18;14:110. doi: 10.1186/s12957-016-0869-6.
2
Prognostic evaluation of the Ki-67 labeling system in histological grading of non-small round cell sarcoma: a supplementary analysis of a randomized controlled trial, JCOG1306.Ki-67 标记系统在非小细胞圆细胞肉瘤组织学分级中的预后评估:JCOG1306 随机对照试验的补充分析。
Jpn J Clin Oncol. 2024 Jun 1;54(6):675-680. doi: 10.1093/jjco/hyae020.
3
Ki-67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the final grade assigned to adult-soft tissue sarcomas. An international collaborative study.Ki-67免疫表达及坏死的影像学评估可提高传统及改良粗针活检系统预测成人软组织肉瘤最终分级的准确性。一项国际合作研究。
Pathol Res Pract. 2021 Sep;225:153562. doi: 10.1016/j.prp.2021.153562. Epub 2021 Jul 22.
4
Federation Nationale des Centers de Lutte Contre le Cancer grading of soft tissue sarcomas on needle core biopsies using surrogate markers.法国国家抗癌中心联合会:使用替代标志物对针芯活检的软组织肉瘤进行分级
Hum Pathol. 2016 Oct;56:147-54. doi: 10.1016/j.humpath.2016.06.008. Epub 2016 Jun 23.
5
Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas.包括相邻器官的扩大切除术和Ki-67标记指数是腹膜后软组织肉瘤患者的预后因素。
World J Surg Oncol. 2016 Feb 24;14(1):43. doi: 10.1186/s12957-016-0810-z.
6
Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.157例子宫肉瘤的临床病理预后因素分析及软组织肉瘤验证分级评分的评估
Cancer. 2000 Mar 15;88(6):1425-31.
7
Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304.四肢高级别软组织肉瘤围手术期多柔比星和异环磷酰胺化疗的 10 年随访结果:日本临床肿瘤学组研究 JCOG0304。
BMC Cancer. 2019 Sep 6;19(1):890. doi: 10.1186/s12885-019-6114-2.
8
Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304).异环磷酰胺和阿霉素用于肢体高级别软组织肉瘤的围手术期化疗(JCOG0304)
Jpn J Clin Oncol. 2015 Jun;45(6):555-61. doi: 10.1093/jjco/hyv042. Epub 2015 Apr 2.
9
Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332.基于风险的策略治疗的低级别非横纹肌肉瘤软组织肉瘤的年轻患者的临床特征和结局:来自儿童肿瘤学组研究 ARST0332 的报告。
Pediatr Blood Cancer. 2024 Aug;71(8):e31062. doi: 10.1002/pbc.31062. Epub 2024 May 16.
10
Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.使用MIB-1的组织学分级系统对成人软组织肉瘤的预后相关性。
Oncology. 2000;58(1):66-74. doi: 10.1159/000012081.

引用本文的文献

1
Impact of Tertiary Lymphoid Structure on Prognosis and Tumor Microenvironment in Undifferentiated Pleomorphic Sarcoma.三级淋巴结构对未分化多形性肉瘤预后及肿瘤微环境的影响
Cancer Sci. 2025 May;116(5):1464-1473. doi: 10.1111/cas.70018. Epub 2025 Feb 25.
2
Soft-tissue sarcoma: modified grading method improves the accuracy of preoperative MRI in predicting patient outcomes.软组织肉瘤:改良分级方法提高了术前MRI预测患者预后的准确性。
Eur Radiol. 2025 Feb 6. doi: 10.1007/s00330-025-11365-y.
3
Comparison of the Mitotic Count With Various Proliferative Markers for the Effective Differentiation of Benign, Borderline, and Malignant Phyllodes Tumors.

本文引用的文献

1
Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304).异环磷酰胺和阿霉素用于肢体高级别软组织肉瘤的围手术期化疗(JCOG0304)
Jpn J Clin Oncol. 2015 Jun;45(6):555-61. doi: 10.1093/jjco/hyv042. Epub 2015 Apr 2.
2
Preoperative and postoperative chemotherapy with ifosfamide and adriamycin for adult high-grade soft-tissue sarcomas in the extremities: Japan Clinical Oncology Group Study JCOG0304.异环磷酰胺联合阿霉素用于成人四肢高级别软组织肉瘤的术前和术后化疗:日本临床肿瘤学组研究JCOG0304
Jpn J Clin Oncol. 2009 Apr;39(4):271-3. doi: 10.1093/jjco/hyn153. Epub 2009 Jan 20.
3
有丝分裂计数与各种增殖标志物用于有效鉴别良性、交界性和恶性叶状肿瘤的比较
Cureus. 2024 Oct 14;16(10):e71494. doi: 10.7759/cureus.71494. eCollection 2024 Oct.
4
Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wall.蛋白质组学分析可改善 Sarculator 列线图对肢体和躯干壁软组织肉瘤的预后风险分层。
Cancer Med. 2024 Jul;13(14):e70026. doi: 10.1002/cam4.70026.
5
Well-Differentiated Liposarcoma That Increased in Size after Menopause: A Case Report and a Review of the Literature.绝经后增大的高分化脂肪肉瘤:一例报告并文献复习
Case Rep Obstet Gynecol. 2024 Feb 24;2024:7599714. doi: 10.1155/2024/7599714. eCollection 2024.
6
Case report: The first account of undifferentiated sarcoma with epithelioid features originating in the pleura.病例报告:首例起源于胸膜的具有上皮样特征的未分化肉瘤。
Front Med (Lausanne). 2024 Feb 1;11:1301941. doi: 10.3389/fmed.2024.1301941. eCollection 2024.
7
New trends in the surgical management of soft tissue sarcoma: The role of preoperative biopsy.软组织肉瘤外科治疗的新趋势:术前活检的作用
World J Clin Oncol. 2023 Feb 24;14(2):89-98. doi: 10.5306/wjco.v14.i2.89.
8
Visual Counting and Automated Image-analytic Assessment of Ki-67 and their Prognostic Value in Synovial Sarcoma.滑膜肉瘤中Ki-67的视觉计数与自动图像分析评估及其预后价值
Cancer Diagn Progn. 2022 Jan 3;2(1):7-14. doi: 10.21873/cdp.10070. eCollection 2022 Jan-Feb.
9
Prognostic usefulness of a modified risk model for solitary fibrous tumor that includes the Ki-67 labeling index.改良的包含 Ki-67 标记指数的孤立性纤维瘤风险模型的预后价值。
World J Surg Oncol. 2022 Feb 1;20(1):29. doi: 10.1186/s12957-022-02497-2.
10
Immunophenotyping of an Unusual Mixed-Type Extraskeletal Osteosarcoma in a Dog.犬类罕见混合型骨外骨肉瘤的免疫表型分析
Vet Sci. 2021 Dec 6;8(12):307. doi: 10.3390/vetsci8120307.
A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma.
局部可切除软组织肉瘤辅助化疗随机对照试验的系统荟萃分析。
Cancer. 2008 Aug 1;113(3):573-81. doi: 10.1002/cncr.23592.
4
Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma.基于阿霉素的化疗用于局部晚期或转移性软组织肉瘤成年患者的姑息治疗。
Cochrane Database Syst Rev. 2003;2003(3):CD003293. doi: 10.1002/14651858.CD003293.
5
Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk.使用MIB-1评分的分级和分期系统在成人四肢和躯干软组织肉瘤患者中的预后意义。
Cancer. 2002 Aug 15;95(4):843-51. doi: 10.1002/cncr.10728.
6
Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas.成人软组织肉瘤组织学诊断及分级的有效性与可重复性
Hum Pathol. 2002 Jan;33(1):111-5. doi: 10.1053/hupa.2002.30184.
7
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.肢体和带骨成人软组织肉瘤的辅助化疗:意大利随机合作试验结果
J Clin Oncol. 2001 Mar 1;19(5):1238-47. doi: 10.1200/JCO.2001.19.5.1238.
8
Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.使用MIB-1的组织学分级系统对成人软组织肉瘤的预后相关性。
Oncology. 2000;58(1):66-74. doi: 10.1159/000012081.
9
Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma.对410例成年软组织肉瘤患者群体进行美国国立癌症研究所与法国癌症中心肉瘤研究组分级系统的比较研究。
J Clin Oncol. 1997 Jan;15(1):350-62. doi: 10.1200/JCO.1997.15.1.350.
10
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.1041例肢体局限性软组织肉瘤患者的预后因素分析。
J Clin Oncol. 1996 May;14(5):1679-89. doi: 10.1200/JCO.1996.14.5.1679.